MRI measures of neurodegeneration in multiple sclerosis: implications for disability, disease monitoring, and treatment
- 11 April 2014
- journal article
- review article
- Published by Springer Science and Business Media LLC in Zeitschrift für Neurologie
- Vol. 262 (1), 1-6
- https://doi.org/10.1007/s00415-014-7340-9
Abstract
No abstract availableKeywords
This publication has 52 references indexed in Scilit:
- DTI Measurements in Multiple Sclerosis: Evaluation of Brain Damage and Clinical ImplicationsMultiple Sclerosis International, 2013
- Recommendations to improve imaging and analysis of brain lesion load and atrophy in longitudinal studies of multiple sclerosisZeitschrift für Neurologie, 2012
- Association between Change in Normal Appearing White Matter Metabolites and Intrathecal Inflammation in Natalizumab-Treated Multiple SclerosisPLOS ONE, 2012
- Multiple sclerosis normal‐appearing white matter: Pathology–imaging correlationsAnnals of Neurology, 2011
- Progressive Multiple Sclerosis and Gray Matter Pathology: An MRI PerspectiveMount Sinai Journal of Medicine: A Journal of Translational and Personalized Medicine, 2011
- The contribution of MRI in assessing cognitive impairment in multiple sclerosisNeurology, 2010
- Rapid semi-automatic segmentation of the spinal cord from magnetic resonance images: Application in multiple sclerosisNeuroImage, 2010
- Segmentation of brain magnetic resonance images for measurement of gray matter atrophy in multiple sclerosis patientsNeuroImage, 2009
- 3D MPRAGE improves classification of cortical lesions in multiple sclerosisMultiple Sclerosis Journal, 2008
- Magnetisation transfer ratio in the normal appearing white matter predicts progression of disability over 1 year in early primary progressive multiple sclerosisJournal of Neurology, Neurosurgery & Psychiatry, 2007